EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of preventive endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis



Effect of preventive endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis



Gastroenterological Endoscopy 31(12): 3180-3193



Prognostic survey on 5-years-survival rate and direct cause of death in 259 patients with liver cirrhosis, including 81 cases complicted by hepatoma, who have received the preventive endoscopic injection sclerotherapy for esophageal varices, was done. Age and each direct cause of death was also inventigated. Results: A 5-years-survival rate was 71.8%, and this result corresponded with those in some recent reports. As the direct causes of death, incidence of bleeding from the rupture of the esophageal varices was only 3.3%, and hepatic failure, 12.2%. On the other hand, hepatoma occupied very high percentage; 72.2%. The deaths caused by non-hepatic diseases relatively frequently encountered; incidence was 20.2%. The ages at death classified by direct causes of death : age at death by varices bleeding and hepatic failure was 60.3 years old, and that by non-hepatic diseases was 66.5 years old.

(PDF emailed within 1 workday: $29.90)

Accession: 007257448

Download citation: RISBibTeXText



Related references

Long-term follow-up of patients with liver cirrhosis after endoscopic ethanol injection sclerotherapy for esophageal varices. Hepato-Gastroenterology 50(53): 1556-1559, 2003

Endoscopic injection sclerotherapy for esophageal varices prolonged survival of patients with hepatocellular carcinoma complicating liver cirrhosis. Gastrointestinal Endoscopy 51(5): 569-572, 2000

Endoscopic variceal ligation is a sufficient procedure for the treatment of esophageal varices in patients with hepatitis-C liver cirrhosis; Comparison with injection sclerotherapy. Gastroenterology 110(4 SUPPL ): A1206, 1996

Branched-chain amino acid supplementation during the endoscopic injection sclerotherapy for esophageal varices may be useful for maintenance of nutritional status in patients with liver cirrhosis. Hepatology Research 32(3): 144-145, 2005

Propofol is a more effective and safer sedative agent than midazolam in endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis: a randomized controlled trial. Fukushima Journal of Medical Science 64(3): 133-141, 2018

Endoscopic and histological study of gastric mucosa in liver cirrhosis with special reference to cases treated with endoscopic injection sclerotherapy for esophageal varices. Gastroenterological Endoscopy 29(10): 2166-2178, 1987

Clinical evaluation of endoscopic injection sclerotherapy for bleeding esophageal varices in liver cirrhosis with hepatocellular carcinoma. Gastroenterologia Japonica 26 Suppl 3: 36-38, 1991

Gastric mucosal blood flow the effect of esophageal transection and endoscopic sclerotherapy for treatment of esophageal varices in liver cirrhosis. Japanese Journal of Gastroenterology 84(4): 833-839, 1987

Prophylactic endoscopic sclerotherapy in patients with liver cirrhosis, portal hypertension, and esophageal varices. Hepato-Gastroenterology 44(15): 625-636, 1997

Analgesic Effects of Oxycodone Relative to Those of Sufentanil, in the Presence of Midazolam, During Endoscopic Injection Sclerotherapy for Patients With Cirrhosis and Esophageal Varices. Anesthesia and Analgesia: -, 2018

Scintigraphic study of gastric emptying after endoscopic sclerotherapy of esophageal varices in patients with alcoholic liver cirrhosis. Gastroenterologie Clinique et Biologique 16(10): 812-812, 1992

Effect of endoscopic sclerotherapy of esophageal varices on the survival of patients with hepatic cirrhosis. Anales de Medicina Interna 11(3): 145-149, 1994

Determination of blood cell count and spleen size in patients with liver cirrhosis submitted to endoscopic sclerotherapy for esophageal varices. Przeglad Lekarski 56(10): 653-655, 2000

Portal venous system after endoscopic sclerotherapy of esophageal varices in patients with liver cirrhosis--prospective study with Doppler sonography. Hepato-Gastroenterology 52(65): 1448-1451, 2005

Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial. Hepato-Gastroenterology 47(33): 733-737, 2000